| Document |
Document Title |
|
JPS4837030B1 |
Cpds. (I) R' = H or F R2 = an ester residue (pref. of a 1-18C acid) R3 and R4 = OH, an ester residue (pref. of a 1-18C acid) or an ether residue (pref. of a 1-8C alcohol) Anti-inflammatories, thymolytics and anti-leukemics.
|
|
JPS4831107B1 |
1313659 Pharmaceutical compositions containing steroids GLAXO LABORATORIES Ltd 13 July 1970 [25 July 1969] 37612/69 Heading ASB [Also in Division C2] Pharmaceutical and veterinary compositions comprise steroids possessing progestational,...
|
|
JPS4830048B1 |
A method for the prepn. of ethers and thioethers of the androstane, estrane, pregnane, and 19-nor-pregnane series. 17-Cycloethylenedioxy-3-hydroxy-estra-1:3:5(10)-triene in T.H.F. (125 ml.), treated (5 h.) with BF3-B2H6. Excess B2H6 dec....
|
|
JPS4830049B1 |
|
|
JPS4829221B1 |
Cpds. of formula: (I) R' = OH, an ether residue derived, e.g. from a (1-8C) alcohol, or an ester residue derived from a (1-18C) carboxylic acid. R2 = X = H or F, or X = R2 a 9(11) double bond; Y = H, OH, or an ester residue (as above). A...
|
|
JPS4829220B1 |
1348701 21-Halogeno-steroids SCHERING AG 19 April 1971 [28 Feb 1970] 22302/71 Heading C2U Novel steroids of the formula (wherein -A-B- is -CH 2 -CH 2 -, -CH= CH- or -CCl=CH- and X is a halogen atom) are prepared by halogenation of the co...
|
|
JPS4828433B1 |
17a - Alkyl - 20 - keto - pregnane compounds, which are novel when they also contain a 16a -alkyl substituent, "alkyl" being possibly unsaturated and, for the 17-substituent, possibly substituted, are prepared by treating D 17(20) - 20 -...
|
|
JPS4821104B1 |
The invention comprises a 10b -n-propyl steroid of the general formula in which A represents the oxygen atom of a keto group and B and C together represent a double bond and D represents a hydrogen atom or A either re...
|
|
JPS4819310B1 |
Cpds. (I) R' = H or F R2 = an ester residue (pref. of a 1-18C acid) R3 and R4 = OH, an ester residue (pref. of a 1-18C acid) or an ether residue (pref. of a 1-8C alcohol) Anti-inflammatories, thymolytics and anti-leukemics.
|
|
JPS4818214B1 |
|
|
JPS4815287B1 |
1,261,650. Antiinflammatory compositions. GLAXO LABORATORIES Ltd. 11 June, 1970 [12 June, 1969], No. 29866/69. Heading A5B. [Also in Division C2] Pharmaceutical compositions for anti-inflammatory use comprise 9α, 21-fluoro-11#- hydroxy-...
|
|
JPS4815290B1 |
21,21-Dichlorosteroids of the formula WHEREIN R1 is a hydrogen or chlorine atom; R2 is a hydrogen atom, a fluorine atom, or a methyl group; R3 is a hydrogen atom or a methyl group; R4 is a hydrogen atom or a free or esterified hydroxy gr...
|
|
JPS4828462A |
A process for converting 17 alpha -vinyl-17 beta -hydroxy steroids to 17-(2-haloethylidene)-steroids, known intermediates for antifungal and progestational agents, by treating the 17 alpha -vinyl-17 beta -hydroxy steroids with vanadium t...
|
|
JPS4810790B1 |
21-halogen steroids having the formula WHEREIN -A-B- is -CH=CH- or -CCl=CH-, Y and Z are each a halogen atom, and X is a halogen atom having the same or a lesser atomic weight than Y and in the case where -A-B- is a -CCl=CH- group, X can...
|
|
JPS4810555B1 |
1,259,492. Hydroxylated steroids. E. R. SQUIBB & SONS Inc. 28 Feb., 1969 [20 March, 1968], No. 10896/69. Heading C2U. [Also in Division C5] Novel compounds of the formulµ (wherein R is H or acyl) are prepared from 21- acetoxy - pregna -...
|
